|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_on1255342665 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m d |
007 |
cr ||||||||||| |
008 |
210606s2021 ts ob 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d UKAHL
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1262314004
|
020 |
|
|
|a 9781681088297
|q (electronic bk.)
|
020 |
|
|
|a 1681088290
|q (electronic bk.)
|
020 |
|
|
|z 9781681088303
|
035 |
|
|
|a (OCoLC)1255342665
|z (OCoLC)1262314004
|
050 |
|
4 |
|a RM265
|
082 |
|
4 |
|a 615.7/92
|2 23/eng/20220517
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Frontiers in anti-infective drug discovery.
|n Volume 9 /
|c edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
|
264 |
|
1 |
|a Sharjah, UAE :
|b Bentham Science Publishers,
|c [2021]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a "This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.- Use of preclinical and early clinical data for accelerating antimicrobial drug development- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives- Current scenario of anti-leishmanial drugs and treatment- Dengue hemorrhagic fever: the potential repurposing drugs."--
|c Provided by publisher
|
504 |
|
|
|a Includes bibliographical references.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Anti-infective agents.
|
650 |
|
0 |
|a Communicable diseases.
|
650 |
|
2 |
|a Anti-Infective Agents
|
650 |
|
2 |
|a Communicable Diseases
|
650 |
|
6 |
|a Antiinfectieux.
|
650 |
|
6 |
|a Maladies infectieuses.
|
650 |
|
7 |
|a Anti-infective agents
|2 fast
|
650 |
|
7 |
|a Communicable diseases
|2 fast
|
700 |
1 |
|
|a Rahman, Atta-ur-,
|d 1942-
|e editor.
|
700 |
1 |
|
|a Chaudhary, M. Iqbal,
|e editor.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2938751
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 302230627
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH38976182
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2938751
|
994 |
|
|
|a 92
|b IZTAP
|